JKSM Stock Overview
Jacksam Corporation, doing business as Convectium, focuses on developing and commercializing products of vaporizer cartridge filling and capping, pre-roll filling, and other automation systems.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Jacksam Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.011 |
52 Week High | US$0.027 |
52 Week Low | US$0.0056 |
Beta | -1.72 |
1 Month Change | 16.67% |
3 Month Change | n/a |
1 Year Change | 5.00% |
3 Year Change | -93.48% |
5 Year Change | -99.05% |
Change since IPO | -98.46% |
Recent News & Updates
Recent updates
Shareholder Returns
JKSM | US Machinery | US Market | |
---|---|---|---|
7D | 8.6% | 0.9% | 1.2% |
1Y | 5.0% | 32.4% | 24.7% |
Price Volatility
JKSM volatility | |
---|---|
JKSM Average Weekly Movement | 65.6% |
Machinery Industry Average Movement | 4.9% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | 7 | Mark Adams | www.jacksamcorp.com |
Jacksam Corporation, doing business as Convectium, focuses on developing and commercializing products of vaporizer cartridge filling and capping, pre-roll filling, and other automation systems. Its products include 710 Shark cartridge filling machines, 710 Captain cartridge capping machines, PreRoll-ER pre-roll and cone filling machines, and C-Cell cartridges. The company markets and sells its products to medical and recreational dispensaries, large and small-scale processors and growers, multi-state operators, and distributors through direct sales force, independent sales representatives, strategic partners’ sales force, and a referral network, as well as its Website.
Jacksam Corporation Fundamentals Summary
JKSM fundamental statistics | |
---|---|
Market cap | US$993.96k |
Earnings (TTM) | -US$1.35m |
Revenue (TTM) | US$1.46m |
0.7x
P/S Ratio-0.7x
P/E RatioIs JKSM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
JKSM income statement (TTM) | |
---|---|
Revenue | US$1.46m |
Cost of Revenue | US$1.22m |
Gross Profit | US$239.04k |
Other Expenses | US$1.59m |
Earnings | -US$1.35m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.014 |
Gross Margin | 16.42% |
Net Profit Margin | -92.85% |
Debt/Equity Ratio | -25.1% |
How did JKSM perform over the long term?
See historical performance and comparison